NEWS

  • All
  • Corporate News
All
  • All
  • Corporate News
Corporate News

Mainz Biomed Announces First Quarter 2022 Results

Read More
Corporate News

Mainz Biomed Completes Successful Pre-Submission Process with the U.S. FDA for ColoAlert’s Pivotal Clinical Trial

Read More
Corporate News

Mainz Biomed to Ring Nasdaq Stock Market Closing Bell

Read More
Corporate News

Mainz Biomed Appoints Key Clinical Trial Partners for ColoFuture Study

Read More
Corporate News

Mainz Biomed Announces Year End 2021 Results

Read More
Corporate News

Mainz Biomed and Partners Join International Awareness Campaign for Colorectal Cancer Awareness Month

Read More

If you would like to be kept up to date with the very latest news, please enter your details in the form and we will keep you updated.

  • This field is for validation purposes and should be left unchanged.